Drug Shortage Report for DEXTROSE INJECTION

Last updated on 2024-03-22 History
Report ID 201190
Drug Identification Number 02517132
Brand name DEXTROSE INJECTION
Common or Proper name Dextrose Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 50%
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 50mL vial / fiole
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-08-07
Estimated end date 2024-05-01
Actual end date 2024-03-21
Shortage status Resolved
Updated date 2024-03-22
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2024-03-22 English Compare
v25 2024-03-21 French Compare
v24 2024-03-21 English Compare
v23 2024-03-21 English Compare
v22 2024-01-30 French Compare
v21 2024-01-30 English Compare
v20 2023-12-19 French Compare
v19 2023-12-19 English Compare
v18 2023-11-27 French Compare
v17 2023-11-27 English Compare
v16 2023-11-06 French Compare
v15 2023-11-06 English Compare
v14 2023-10-30 French Compare
v13 2023-10-30 English Compare
v12 2023-10-16 French Compare
v11 2023-10-16 French Compare
v10 2023-10-16 English Compare
v9 2023-09-11 French Compare
v8 2023-09-11 English Compare
v7 2023-09-05 English Compare

Showing 1 to 20 of 26